A CE-IVD certified in-vitro diagnostic device for qualitative detection of elevated tyrosine levels in urine. Designed for orientational screening in preventive care workflows.
CCI Reagent is a single-use rapid test that detects elevated levels of monohydroxyphenol metabolites (tyrosine) in a first-morning urine sample. Elevated urinary tyrosine can be associated with certain metabolic and proliferative conditions, making it a relevant biomarker for orientational screening.
The test uses a colorimetric chemical reaction inside a sealed ampule. A urine sample is added to the ampule using the included pipette; the resulting colour change is compared against the reference scale provided after 3–5 minutes. No laboratory infrastructure is required.
Important: CCI Reagent is an orientational screening tool. It does not provide a clinical diagnosis. Positive or borderline results require confirmation through standard clinical diagnostic procedures.
CCI Reagent is intended for in-vitro diagnostic use as an orientational screening aid for the detection of elevated tyrosine levels in urine. The test is designed for use by healthcare professionals, trained laboratory personnel, and — where permitted by local regulation — informed lay users.
The test is not intended as a standalone diagnostic tool. Results should be interpreted in the context of clinical history and confirmed by appropriate laboratory methods.
Request the distributor pack for complete regulatory documentation, product samples, and commercial terms.
Request the distributor pack — including regulatory documentation, pricing tiers, and logistics specifications. No commitment. Full transparency.
We use essential cookies to operate this website. No tracking or marketing cookies are used. By continuing, you accept our cookie policy.